$8.69 0.17 (+2.00%)
11/25/2009 12:56 PM

Albany Molecular Research, Inc. (AMRI)

CAPS Rating: 3 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Featured Broker Partners